BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other European partnering conference. 80 investment firms are expected and 90 companies will be presenting in the showcase. OriBase Pharma has been selected to present its R&D projects at this largest annual biopartnering meeting in Europe.
We will be presenting in the Company Showcase at BioTrinity in Newbury on the 14-16th May 2013. If you would like to arrange a meeting with us, please request a meeting with us via the partnering system by registering at www.biotrinity.com.